Make your drug development a success!

Based on Model-Informed Drug Development, PhInc. Modeling helps you to increase the confidence in decision making and reduces cycle time of your development.
PhinC. Services
News
Join us

Careers

Discover our job offers!

We are regularly looking for dynamic and motivated applicants in pharmacometrics, data science, programming, biostatistics, etc.
Read more

They trust us

Agnes Hemon
Agnes Hemon
Preclinical and P.K clinical Officer - HRA Pharma
PhinC is one of HRA Pharma’s valuable partners for pharmacokinetic studies. From just an advice to modelling, we know we can trust them to efficiently support and carry out our projects.
Sakina Sayah-Jeanne
Sakina Sayah-Jeanne
Senior Director, Translational R&D - Da Volterra
PhinC has been accompanying Da Volterra for several years on PBPK Modelling activities. Our collaboration, based on mutual trust, has already been very fruitful and has allowed Da Volterra to gain precious knowledge on its product under development. Da Volterra enjoys working with PhinC and will continue to do so in the years to come, leaning from its expertise.
John DiBella
John DiBella
President, Lancaster Division - Simulations Plus, Inc. (NASDAQ: SLP)
Simulations Plus has formed a strong relationship with PhinC as we work together to drive increased adoption of physiologically-based pharmacokinetic (PBPK) modeling to support pharmaceutical research and development. Their talented team of scientists have become proficient users of our GastroPlus™ software platform, and we are confident that the services they provide to clients are valuable and greatly impact R&D productivity.
BioQuébec
Montreal International
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
AFPT